Specific outcome measures (for tracking rates) and process measures (to determine adherence to recommended practices) should be identified in individual organizations, based on areas that have been identified for performance improvement. Assuming baseline rates would have remained stable without the study intervention, an estimated total of 2,187â2,419 CLABSIs were prevented over the course of the project. After weighting and adjusting to 2012 dollars, the average CLABSI cost reported in the literature was $70,696 with a range (± two standard deviations) of $40,412â$100,980. Method to Calculate Central Line Infections Flawed. The CDC provides national data on infection rates through the National Healthcare Safety Network. Central line-associated bloodstream infections (CLABSI) are among the most common healthcare-acquired infections in the neonatal intensive care unit (NICU) population and are associated with an increased risk of morbidity and mortality, as well as increased healthcare costs, and â¦ Initial goals of the project were to measure the burden of CLABSI outside the ICU and track the rate of CLABSI after feedback of these rates to the unit staff and hospital administration. â¢ Use central line days to calculate infection rates # of CLABSI x 1000 Central line days â¢ Compare your CLABSI rates over time to assess prevention progress â¢ Make comparisons only with similar patient populations (e.g., same unit with same type of patients over time) 25. Example of CLABSI Rate Calculation: Example of CL Utilization Ratio: [Source: CDC. Pooled Cumulative Incidence Densities for CLABSI in Adult ICU Patients, WHO Data 1995â2010 (corresponding to Table 6-2. of CLABSI Monograph, page 105) CLABSI Rates per 1,000 Central LineâDays in Limited-Resource Countries (2002â2011) (corresponding to Appendix B of CLABSI Monograph, pages 115â118) Process measures. This policy would focus on only placing multi-lumen PICCs if they were medically indicated. Based on the findings of the ICHE paper âLimiting the Number of Lumens in Peripherally Inserted Central Catheters to Improve Outcomes and Reduce Cost: A Simulation Studyâ our CLABSI cost calculator will show you the savings your hospital could expect if you implemented a single-lumen PICC only policy. These measures can be used to identify the level of use of central venous catheters (CVC) in a facility or organization and the rate of CLABSI in patients who are at risk for CLABSI due to the use of a CVC. CLABSI is a type of healthcare-associated infection (HAI). 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 2019-Q2 2019-Q3 2019-Q4 2020-Q1 2020-Q2 s ICU Catheter-Associated Urinary Tract Infections (CAUTI) Rate 1. âWe saw 74 CLABSI in 10,065 line days; 26.6 were predicted.â 2. âThe SIR is 2.78, or nearly 3 times higher than what would be predicted from national data.â 3. âThis is significantly different than the national hospital data.â 4. âIn fact, the precision of this estimate shows that our hospital is FRIDAY, Aug. 9, 2019 -- Using the true number of central lines as the denominator improves methods of determining central line-associated bloodstream infection (CLABSI) rates, according to a study published â¦ ICU CLABSI Rate NHSN ICU Benchmark 2013 CDC National Healthcare Safety Network (NHSN) Benchmark: Critical Care Units, Medical/Surgical -major teaching mean 1.1. Among patients with multiple concurrent central lines, an ICU stay, a longer admission, a dialysis catheter, and a CLABSI were more likely. Using the modified denominator reduced CLABSI rates by 25 percent in ICUs (1.95 versus 1.47 per 1,000 line days) and 6 percent in non-ICUs (1.30 versus 1.22 per 1,000 line days). Columns are provided for the number of CLABSIs, the number of central line days, and the CLABSI rate. HAIs are infections that patients can get while receiving medical treatment in a healthcare facility. AJIC 2004;32:470-85]- Device associated infection : An infection in a patient with a device (e.g., ventilator or central line) that was used within the 48-hour period before onset of infection. Working toward the elimination of HAIs is a CDC priority.